CNTN4

CNTN4 (BIG-2) is a GPI-anchored, Ig- and fibronectin type III (FnIII)-domain cell adhesion molecule that promotes axon growth and synaptic connectivity in the developing nervous system (PMID:8586965, PMID:34415325). As a substrate, recombinant CNTN4 directly promotes neurite outgrowth, and in vivo it acts as an axon guidance cue: loss of CNTN4 causes olfactory sensory neurons expressing a given odorant receptor to mistarget to multiple ectopic glomeruli, disrupting odor-map formation (PMID:8586965, PMID:18367085). Beyond wiring, CNTN4 shapes synapse structure and function — it promotes dendritic spine formation and excitatory synapse number in cortical neurons, and its loss reduces CA1 hippocampal LTP, alters dendritic arborization and spine density, and produces gene-dose-dependent behavioral changes (PMID:33542194, PMID:34415325). Spine-promoting activity requires intact signal peptide, FnIII, and GPI domains, and autism-associated CNTN4 variants fail to rescue spine density and neural activity, tying these domains to neurodevelopmental disease risk (PMID:34415325). CNTN4 also modulates the brain-region-specific surface expression of glutamate (GluA1, GluA2, GluN1) and GABA-A (α1) receptors (PMID:29970989), and it forms a functional complex with amyloid precursor protein (APP) that controls neurite/neural elongation in cortical neurodevelopment (PMID:38745463). A non-neuronal role is documented in which CNTN4 acts as a direct target of miR-148a-3p in macrophage inflammatory signaling (PMID:36544657).

1. 1995 Medium

   Established CNTN4 as a GPI-anchored adhesion molecule with a direct, intrinsic capacity to drive axon growth, defining its baseline molecular activity.

   Evidence Molecular cloning, domain analysis, and in vitro neurite outgrowth assays using recombinant BIG-2 as a substrate

   PMID:8586965

   Open questions at the time

   • No in vivo confirmation of the outgrowth-promoting role
   • Binding partner mediating outgrowth not identified
   • Domain requirements not yet dissected
2. 1997 Low

   Showed that alternative splicing yields a GPI-anchorless isoform (BIG-2A) restricted to mature chemosensory neuroepithelia, raising the possibility of splice-variant-specific functions.

   Evidence cDNA cloning and in situ hybridization in adult and developing mice

   PMID:9221934

   Open questions at the time

   • Expression localization only; no functional manipulation of the isoform
   • Functional distinction between GPI-anchored and anchorless forms untested
   • Single lab, no orthogonal validation
3. 2008 High

   Demonstrated in vivo that CNTN4 is required for olfactory sensory axon convergence onto correct glomeruli, establishing it as a bona fide axon guidance molecule for odor-map formation.

   Evidence BIG-2 knockout mouse with olfactory axon tracing and glomerular mapping

   PMID:18367085

   Open questions at the time

   • Molecular guidance partners/receptors not identified
   • Whether guidance uses the same domains as in vitro outgrowth unknown
4. 2018 Medium

   Revealed that CNTN4 modulates surface availability of excitatory and inhibitory neurotransmitter receptors in a brain-region-specific manner, extending its role from wiring to synaptic receptor regulation.

   Evidence Surface biotinylation and western blotting for glutamate and GABA-A receptor subunits across brain regions in Cntn4-/- mice

   PMID:29970989

   Open questions at the time

   • Mechanism linking CNTN4 to receptor surface trafficking unknown
   • Direct physical interaction with receptors not shown
   • Single lab
5. 2021 High

   Connected CNTN4 to hippocampal synaptic plasticity and behavior, showing its loss impairs CA1 LTP, alters dendritic morphology/spine density, and produces gene-dose-dependent fear-memory changes.

   Evidence Hippocampal slice electrophysiology, neuroanatomy, and fear-conditioning behavior in Cntn4 KO mice

   PMID:33542194

   Open questions at the time

   • Molecular pathway from CNTN4 to LTP not resolved
   • Cell-autonomous vs circuit-level contributions not separated
6. 2021 High

   Mapped CNTN4's spine-promoting activity to specific domains and linked autism-associated variants to functional loss, providing a structure-function basis for disease risk.

   Evidence Domain-deletion mutant rescue, spine counting, electrophysiology, and analysis of autism-linked variants in cortical neurons

   PMID:34415325

   Open questions at the time

   • Binding partner engaged by FnIII domains for spine formation not identified
   • Single lab
7. 2024 Medium

   Identified APP as a CNTN4 binding partner and showed the CNTN4-APP complex is required for neural elongation, providing a molecular partner for CNTN4's developmental morphology functions.

   Evidence Mass spectrometry interaction screen plus single and double CNTN4/APP knockout human cell lines with neural elongation assays

   PMID:38745463

   Open questions at the time

   • Structural basis and stoichiometry of the CNTN4-APP interaction unknown
   • Whether APP mediates the olfactory guidance or synaptic phenotypes not tested
   • Single lab
8. 2022 Medium

   Documented a non-neuronal regulatory context in which CNTN4 is a direct miR-148a-3p target controlling macrophage apoptosis and inflammatory cytokine output.

   Evidence Dual-luciferase 3'UTR reporter, qRT-PCR, flow cytometry, and ELISA in oxLDL-treated THP-1 macrophages

   PMID:36544657

   Open questions at the time

   • Mechanism by which CNTN4 influences macrophage inflammation unknown
   • Relevance to CNTN4's neuronal functions unclear
   • Single lab, non-neuronal model

• The receptors/ligands through which CNTN4 transduces axon guidance, receptor-surface regulation, and synaptic plasticity signals remain largely undefined beyond the APP interaction.
• No guidance receptor identified for olfactory axon targeting
• Mechanistic link between CNTN4 and glutamate/GABA receptor trafficking unresolved
• Downstream signaling effectors of spine formation unknown